C12N 2760/20143
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2760/20143 (Viral genome or elements thereof as genetic vector) appears on 23 US grants and 41 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 41
- Assignees
- 30
- Inventors
- 68
- Latest grant
- 8 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 2 |
| 2004 | 1 | 1 |
| 2005 | 0 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 2 | 4 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 2 | 4 |
| 2022 | 2 | 2 |
| 2023 | 3 | 7 |
| 2024 | 2 | 3 |
| 2025 | 2 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Multivalent vaccines for rabies virus and coronaviruses8 Apr 2025US 12,269,155 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Self-inactivating rabies virus vector encoding a nucleoprotein and degron21 Jan 2025US 12,203,092 B2Mironid Limited
- Coronavirus disease (COVID-19) vaccine7 May 2024US 11,975,067 B2Thomas Jefferson University
- RNA-based delivery systems with levels of control2 Apr 2024US 11,946,066 B2California Institute of Technology
- Apparatus for releasably holding a socket28 Nov 2023US 11,826,895 B2
- A therapeutic against crimean-congo hemorrhagic fever virus6 Feb 2025US 2025/0041398 A1Thomas Jefferson University
- Chimeric pseudotyped recombinant rabies virus3 Oct 2024US 2024/0327802 A1Beam Therapeutics Inc.
- Adjuvanted inactivated recombinant rabies virus vectored coronavirus vaccine formulations18 Jul 2024US 2024/0238411 A1Bharat Biotech International Limited
- Compositions and methods for tracing cell networks9 May 2024US 2024/0151709 A1The Brigham and Women S Hospital, Inc.
- Gene shuffled lyssavirus vaccine14 Dec 2023US 2023/0398201 A1Thomas Jefferson University
Most cited
By later US patents
- Recombinant infectious non-segmented negative strand RNA virus156US 6,033,886 A2000
- Apparatus for releasably holding a socket11US 11,091,778 B22021
- Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife5US 7,074,413 B2Thomas Jefferson University · 2006
- Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS3US 6,706,523 B2University of Georgia Research Foundation, Inc. · 2004
- Rabies virus vector systems and compositions and methods thereof3US 7,863,041 B2The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · 2011